Direct health-care cost utilization in Hong Kong inflammatory bowel disease patients in the initial 2 years following diagnosis.
Loey Lung-Yi MakSiew C NgIrene O L WongMichael K K LiF H LoMarc T L WongC M LeungSteven W C TsangK H ChanS F SzeEdwin H S ShanBelsy C Y LamAric J HuiIvan F N HungWai K LeungPublished in: Journal of gastroenterology and hepatology (2018)
Hospitalization and 5-aminosalicylic acid usage accounted for 56% of total direct medical costs in the first 2 years of our newly diagnosed IBD patients. Direct health-care costs were higher in the first year compared with the second year of diagnosis. Surgery and low hemoglobin on presentation were associated with high cost outliers.
Keyphrases
- newly diagnosed
- healthcare
- end stage renal disease
- ejection fraction
- chronic kidney disease
- prognostic factors
- minimally invasive
- coronary artery disease
- coronary artery bypass
- acute coronary syndrome
- patient reported outcomes
- social media
- percutaneous coronary intervention
- patient reported
- health insurance
- affordable care act